logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10047103 B1

PDFFull Text
Date of Patent:
Aug. 14, 2018

Filed:

May. 12, 2017

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation

Applicants:

Bristol-myers Squibb Company, Princeton, NJ (US);

Universite DE Montreal, Montreal, CA;

Inventors:

Jacques Banville, Saint-Hubert, CA;

Roger Remillard, Napierville, CA;

Edward H. Ruediger, Greenfield Park, CA;

Daniel H. Deon, Denver, CO (US);

Marc Gagnon, Ville Saint-Laurent, CA;

Laurence Dube, Laval, CA;

Julia Guy, Montreal, CA;

Eldon Scott Priestley, Yardley, PA (US);

Shoshana L. Posy, Highland Park, NJ (US);

Brad D. Maxwell, Doylestown, PA (US);

Pancras C. Wong, Plainsboro, NJ (US);

R. Michael Lawrence, Yardley, PA (US);

Michael M. Miller, Pennington, NJ (US);

Assignees:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Universite de Montreal, Montreal, CA;

Attorney:

Hoffman & Baron, LLP

Primary Examiner:

Matthew P Coughlin

Int. Cl.
CPC ...
C07D 513/04 (2006.01); C07D 487/04 (2006.01); C07D 519/00 (2006.01); A61K 45/06 (2006.01); A61K 31/433 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/5025 (2006.01); A61K 31/5377 (2006.01); A61K 31/541 (2006.01); A61K 31/553 (2006.01); A61K 31/435 (2006.01); A61K 31/5386 (2006.01); A61K 31/55 (2006.01); A61K 51/04 (2006.01); C07B 59/00 (2006.01);
U.S. Cl.
CPC ...
C07D 513/04 (2013.01); A61K 31/433 (2013.01); A61K 31/435 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/5025 (2013.01); A61K 31/5377 (2013.01); A61K 31/5386 (2013.01); A61K 31/541 (2013.01); A61K 31/55 (2013.01); A61K 31/553 (2013.01); A61K 45/06 (2013.01); A61K 51/0453 (2013.01); C07B 59/002 (2013.01); C07D 487/04 (2013.01); C07D 519/00 (2013.01); C07B 2200/05 (2013.01);
Abstract

The present invention provides thiazole compounds of Formula I wherein W, Y, R, R, R, R, R, R, X, X, Xand Xare as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug ester or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.

Find Patent Forward Citations

Loading…